HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: HER2 aberrations in salivary gland carcinomas (SGC) as well as benefit of HER2 directed therapy have been reported in small studies. However, reliable estimates of the prevalence of HER2 positivity in SGC and its various histological subtypes are lacking. OBJECTIVE: To assess the prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Egebjerg, Kristian, Harwood, Cecilie Dupont, Woller, Nina Claire, Kristensen, Claus Andrup, Mau-Sørensen, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264509/
https://www.ncbi.nlm.nih.gov/pubmed/34249747
http://dx.doi.org/10.3389/fonc.2021.693394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264509/
https://www.ncbi.nlm.nih.gov/pubmed/34249747
http://dx.doi.org/10.3389/fonc.2021.693394

Ejemplares similares